Weighted Average Number of Shares Outstanding, Basic of NANOVIRICIDES, INC. from 30 Jun 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
NANOVIRICIDES, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2013 to 31 Dec 2025.
  • NANOVIRICIDES, INC. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 19,850,080, a 36% increase year-over-year.
  • NANOVIRICIDES, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 15,116,548, a 27% increase from 2024.
  • NANOVIRICIDES, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 11,871,054, a 2.1% increase from 2023.
  • NANOVIRICIDES, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 11,626,220, a 0.79% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

NANOVIRICIDES, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 19,850,080 +5,278,038 +36% 01 Oct 2025 31 Dec 2025 10-Q 17 Feb 2026 2026 Q2
Q3 2025 17,082,425 +3,366,466 +25% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2026 Q1
Q2 2025 15,116,548 +3,245,494 +27% 01 Apr 2025 30 Jun 2025 10-K 29 Sep 2025 2025 FY
Q1 2025 16,026,318 +4,246,739 +36% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q3
Q4 2024 14,572,042 +2,826,136 +24% 01 Oct 2024 31 Dec 2024 10-Q 17 Feb 2026 2026 Q2
Q3 2024 13,715,959 +1,997,168 +17% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2026 Q1
Q2 2024 11,871,054 +244,834 +2.1% 01 Apr 2024 30 Jun 2024 10-K 29 Sep 2025 2025 FY
Q1 2024 11,779,579 +143,538 +1.2% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q3
Q4 2023 11,745,906 +135,603 +1.2% 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2025 2025 Q2
Q3 2023 11,718,791 +126,424 +1.1% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2025 Q1
Q2 2023 11,626,220 +91,522 +0.79% 01 Apr 2023 30 Jun 2023 10-K 27 Sep 2024 2024 FY
Q1 2023 11,636,041 +95,745 +0.83% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q3
Q4 2022 11,610,303 +84,999 +0.74% 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024 2024 Q2
Q3 2022 11,592,367 +77,088 +0.67% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2024 Q1
Q2 2022 11,534,698 +633,743 +5.8% 01 Apr 2022 30 Jun 2022 10-K 13 Oct 2023 2023 FY
Q1 2022 11,540,296 +587,244 +5.4% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q3
Q4 2021 11,525,304 +859,248 +8.1% 01 Oct 2021 31 Dec 2021 10-Q 14 Feb 2023 2023 Q2
Q3 2021 11,515,279 +1,027,678 +9.8% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2023 Q1
Q2 2021 10,900,955 01 Apr 2021 30 Jun 2021 10-K 13 Oct 2022 2022 FY
Q1 2021 10,953,052 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q3
Q4 2020 10,666,056 01 Oct 2020 31 Dec 2020 10-Q 14 Feb 2022 2021 Q2
Q3 2020 10,487,601 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q1
Q2 2018 64,920,856 +4,818,001 +8% 01 Apr 2018 30 Jun 2018 10-K 12 Oct 2018 2018 FY
Q1 2018 64,068,378 +3,065,437 +5% 01 Jan 2018 31 Mar 2018 10-Q 21 May 2018 2018 Q3
Q4 2017 63,335,601 +5,130,107 +8.8% 01 Oct 2017 31 Dec 2017 10-Q 20 Feb 2018 2018 Q2
Q3 2017 63,307,083 +5,127,134 +8.8% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2017 2018 Q1
Q2 2017 60,102,855 +2,433,383 +4.2% 01 Apr 2017 30 Jun 2017 10-K 12 Oct 2018 2018 FY
Q1 2017 61,002,941 +3,166,171 +5.5% 01 Jan 2017 31 Mar 2017 10-Q 21 May 2018 2018 Q3
Q4 2016 58,205,494 +617,413 +1.1% 01 Oct 2016 31 Dec 2016 10-Q 20 Feb 2018 2018 Q2
Q3 2016 58,179,949 +905,634 +1.6% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2018 Q1
Q2 2016 57,669,472 +1,115,624 +2% 01 Apr 2016 30 Jun 2016 10-K 12 Oct 2018 2018 FY
Q1 2016 57,836,770 +895,648 +1.6% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q3
Q4 2015 57,588,081 +1,030,729 +1.8% 01 Oct 2015 31 Dec 2015 10-Q 14 Feb 2017 2017 Q2
Q3 2015 57,274,315 +1,698,115 +3.1% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016 2017 Q1
Q2 2015 56,553,848 01 Apr 2015 30 Jun 2015 10-K 28 Sep 2017 2017 FY
Q1 2015 56,941,122 +3,622,386 +6.8% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q3
Q4 2014 56,557,352 +6,525,989 +13% 01 Oct 2014 31 Dec 2014 10-Q 09 Feb 2016 2016 Q2
Q3 2014 55,576,200 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015 2016 Q1
Q1 2014 53,318,736 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q3
Q4 2013 50,031,363 01 Oct 2013 31 Dec 2013 10-Q 25 Feb 2015 2015 Q2

NANOVIRICIDES, INC. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 15,116,548 +3,245,494 +27% 01 Jul 2024 30 Jun 2025 10-K 29 Sep 2025 2025 FY
2024 11,871,054 +244,834 +2.1% 01 Jul 2023 30 Jun 2024 10-K 29 Sep 2025 2025 FY
2023 11,626,220 +91,522 +0.79% 01 Jul 2022 30 Jun 2023 10-K 27 Sep 2024 2024 FY
2022 11,534,698 +633,743 +5.8% 01 Jul 2021 30 Jun 2022 10-K 13 Oct 2023 2023 FY
2021 10,900,955 01 Jul 2020 30 Jun 2021 10-K 13 Oct 2022 2022 FY
2018 64,920,856 +4,818,001 +8% 01 Jul 2017 30 Jun 2018 10-K 12 Oct 2018 2018 FY
2017 60,102,855 +2,433,383 +4.2% 01 Jul 2016 30 Jun 2017 10-K 12 Oct 2018 2018 FY
2016 57,669,472 +1,115,624 +2% 01 Jul 2015 30 Jun 2016 10-K 12 Oct 2018 2018 FY
2015 56,553,848 +5,328,226 +10% 01 Jul 2014 30 Jun 2015 10-K 28 Sep 2017 2017 FY
2014 51,225,622 +5,333,073 +12% 01 Jul 2013 30 Jun 2014 10-K 16 Sep 2016 2016 FY
2013 45,892,549 01 Jul 2012 30 Jun 2013 10-K 14 Sep 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.